Roles of tRNA in cell wall biosynthesis

Wiley Interdisciplinary Reviews: RNA

Volumn 3, Issue 2, 2012, Pages 247-264

  Dare, Kiley ^a   Ibba, Michael ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMINOACYL PHOSPHATIDYLGLYCEROL SYNTHASE; BACTERIAL ENZYME; BACTERICIDE; BETA LACTAM; DIAMINOPIMELIC ACID; FEM PROTEIN; LYSINE; PENTAPEPTIDE; PEPTIDOGLYCAN; PHOSPHATIDYLGLYCEROL; SYNTHETASE; TRANSFER RNA; UNCLASSIFIED DRUG; VANCOMYCIN;

AMINO TERMINAL SEQUENCE; ANTIBIOTIC BIOSYNTHESIS; ANTIBIOTIC RESISTANCE; BACTERIAL METABOLISM; BACTERIUM; BIOSYNTHESIS; CARBOXY TERMINAL SEQUENCE; CELL WALL; ENZYME MODIFICATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; HYDROPHILICITY; LIPID BILAYER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MODULATION; NEWT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; REVIEW; RNA TRANSLATION;

AMINOACYLTRANSFERASES; BACTERIA; BACTERIAL PROTEINS; CELL WALL; DRUG RESISTANCE, BACTERIAL; PEPTIDOGLYCAN; RNA, TRANSFER;

BACTERIA (MICROORGANISMS);

EID: 84864977835     PISSN: 17577004     EISSN: 17577012     Source Type: Journal    
DOI: 10.1002/wrna.1108     Document Type: Review

References (136)

1. Banerjee R, Chen S, Dare K, Gilreath M, Praetorius-Ibba M, Raina M, Reynolds NM, Rogers T, Roy H, Yadavalli SS, et al. tRNAs: cellular barcodes for amino acids. FEBS Lett 2010, 584:387-395. Available at:
2. Watanabe K, Toh Y, Suto K, Shimizu Y, Oka N, Wada T, Tomita K. Protein-based peptide-bond formation by aminoacyl-tRNA protein transferase. Nature 2007, 449: 867-871. Available at:
3. Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med 2001, 193:1067-1076. Available at:
4. Klein S, Lorenzo C, Hoffmann S, Walther JM, Storbeck S, Piekarski T, Tindall BJ, Wray V, Nimtz M, Moser J. Adaptation of Pseudomonas aeruginosa to various conditions includes tRNA-dependent formation of alanyl-phosphatidylglycerol. Mol Microbiol 2009, 71:551-565.
5. Severin A, Tabei K, Tenover F, Chung M, Clarke N, Tomasz A. High level oxacillin and vancomycin resistance and altered cell wall composition in Staphylococcus aureus carrying the staphylococcal mecA and the enterococcal vanA gene complex. J Biol Chem 2004, 279:3398-3407.
6. Peschel A, Sahl H-G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 2006, 4:529-536. Available at:
7. Roy H, Ibba M. Broad range amino acid specificity of RNA-dependent lipid remodeling by multiple peptide resistance factors. J Biol Chem 2009, 284:29677-29683. Available at:
8. Roy H. Tuning the properties of the bacterial membrane with aminoacylated phosphatidylglycerol. IUBMB Life 2009, 61:940-953.
9. Staubitz P, Peschel A. MprF-mediated lysinylation of phospholipids in Bacillus subtilis-protection against bacteriocins in terrestrial habitats? Microbiology (Reading, Engl) 2002, 148:3331-3332. Available at:
10. Thedieck K, Hain T, Mohamed W, Tindall BJ, Nimtz M, Chakraborty T, Wehland J, Jänsch L. The MprF protein is required for lysinylation of phospholipids in listerial membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes. Mol Microbiol 2006, 62:1325-1339. Available at:
11. Hebecker S, Arendt W, Heinemann IU, Tiefenau JH, Nimtz M, Rohde M, Söll D, Moser J. Alanyl- phosphatidylglycerol synthase: mechanism of substrate recognition during tRNA-dependent lipid modification in Pseudomonas aeruginosa. Mol Microbiol 2011, 80:935-950.
12. Ernst CM, Staubitz P, Mishra NN, Yang S-J, Hornig G, Kalbacher H, Bayer AS, Kraus D, Peschel A. The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS Pathog 2009, 5:e1000660. Available at:
13. Ernst CM, Peschel A. Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids. Mol Microbiol 2011, 80:290-299.
14. Julian K, Kosowska-Shick K, Whitener C, Roos M, Labischinski H, Rubio A, Parent L, Ednie L, Koeth L, Bogdanovich T, et al. Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis. Antimicrobial Agents and Chemotherapy 2007, 51:3445-3448. Available at:
15. Murthy MH, Olson ME, Wickert RW, Fey PD, Jalali Z. Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate. Journal of medical microbiology 2008, 57:1036-1038. Available at:
16. Yang S-J, Xiong YQ, Dunman PM, Schrenzel J, Francois P, Peschel A, Bayer AS. Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains. Antimicrobial Agents and Chemotherapy 2009, 53:2636-2637.
17. Friedman L, Alder JD, Silverman JA. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 2006, 50:2137-2145. Available at:
18. Kosowska-Shick K, Clark C, Pankuch GA, McGhee P, Dewasse B, Beachel L, Appelbaum PC. Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies. Antimicrob Agents Chemother 2009, 53:4217-4224.
19. Rubio A, Conrad M, Haselbeck RJ, G C K, Brown-Driver V, Finn J, Silverman JA. Regulation of mprF by antisense RNA restores daptomycin susceptibility to daptomycin-resistant isolates of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 2011, 55:364-367. Available at:
20. Yang S-J, Nast CC, Mishra NN, Yeaman MR, Fey PD, Bayer AS. Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms. Antimicrobial Agents and Chemotherapy 2010, 54:3079-3085. Available at:
21. Maloney E, Stankowska D, Zhang J, Fol M, Cheng Q-J, Lun S, Bishai WR, Rajagopalan M, Chatterjee D, Madiraju MV. The two-domain LysX protein of Mycobacterium tuberculosis is required for production of lysinylated phosphatidylglycerol and resistance to cationic antimicrobial peptides. PLoS Pathog 2009, 5:e1000534. Available at:
22. Roy H, Ibba M. RNA-dependent lipid remodeling by bacterial multiple peptide resistance factors. Proc Natl Acad Sci USA 2008, 105:4667-4672. Available at:
23. Houtsmuller UM, van Deenen L. Identification of a bacterial phospholipid as an O-ornithine ester of phosphatidyl glycerol. Biochim Biophys Acta 1963, 70:211-213.
24. Gould RM, Lennarz WJ. Biosynthesis of aminoacyl derivatives of phosphatidylglycerol. Biochem Biophys Res Commun 1967, 26:512-515.
25. Kocun FJ. Amino acid containing phospholipids as major components of the phospholipids of Streptococcus faecalis 10C1. Biochim Biophys Acta 1970, 202:277-282.
26. Oku Y, Kurokawa K, Ichihashi N, Sekimizu K. Characterization of the Staphylococcus aureus mprF gene, involved in lysinylation of phosphatidylglycerol. Microbiology (Reading, Engl) 2004, 150:45-51. Available at:
27. Nesbitt JA 3rd, Lennarz WJ. Participation of aminoacyl transfer ribonucleic acid in aminoacyl phosphatidylglycerol synthesis. I. Specificity of lysyl phosphatidylglycerol synthetase. J Biol Chem 1968, 243:3088-3095.
28. Staubitz P, Neumann H, Schneider T. MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS microbiol Lett 2004, 231:67-71. Available at:
29. Sohlenkamp C, Galindo-Lagunas KA, Guan Z, Vinuesa P, Robinson S, Thomas-Oates J, Raetz CRH, Geiger O. The lipid lysyl-phosphatidylglycerol is present in membranes of Rhizobium tropici CIAT899 and confers increased resistance to polymyxin B under acidic growth conditions. Mol Plant Microbe Interact 2007, 20:1421-1430. Available at:
30. Roy H, Ibba M. Monitoring Lys-tRNA(Lys) phosphatidylglycerol transferase activity. Methods 2008, 44:164-169. Available at:
31. Gould RM, Thornton MP, Liepkalns V, Lennarz WJ. Participation of aminoacyl transfer ribonucleic acid in aminoacyl phosphatidylglycerol synthesis. II. Specificity of alanyl phosphatidylglycerol synthetase. J Biol Chem 1968, 243:3096-3104.
32. Lennarz WJ, Bonsen PP, van Deenen LL. Substrate specificity of O-L-lysylphosphatidylglycerol synthetase. Enzymatic studies on the structure of O-L-lysylphosphatidylglycerol. Biochemistry 1967, 6:2307-2312.
33. Bonsen PP, de Haas GH, van Deenen LL. Synthetic and structural investigations on 3-phosphatidyl-1′-(3′-O-L-lysyl)glycerol. Biochemistry 1967, 6:1114-1120.
34. Tocanne JF, Verheij HM, den Kamp JA, van Deenen LL. Chemical and physicochemical studies of lysylphosphatidylglycerol derivatives. Occurrence of a2′ yields 3′ lysyl migration. Chem Phys Lipids 1974, 13:389-403.
35. Peschel A. How do bacteria resist human antimicrobial peptides? Trends Microbiol 2002, 10:179-186. Available at:
36. Fischer W, Arneth-Seifert D. D-Alanylcardiolipin, a major component of the unique lipid pattern of Vagococcus fluvialis. J Bacteriol 1998, 180:2950-2957.
37. Fischer W, Leopold K. Polar lipids of four Listeria species containing L-lysylcardiolipin, a novel lipid structure, and other unique phospholipids. Int J Syst Bacteriol 1999, 49(Pt 2):653-662.
38. Samant S, Hsu F-F, Neyfakh AA, Lee H. The Bacillus anthracis protein MprF is required for synthesis of lysylphosphatidylglycerols and for resistance to cationic antimicrobial peptides. J Bacteriol 2009, 191:1311-1319.
39. Gao JL, Weissenmayer B, Taylor AM, Thomas-Oates J, Lopez-Lara IM, Geiger O. Identification of a gene required for the formation of lyso-ornithine lipid, an intermediate in the biosynthesis of ornithine-containing lipids. Mol Microbiol 2004, 53:1757-1770.
40. Khuller GK, Subrahmanyam D. On the ornithinyl ester of phosphatidylglycerol of Mycobacterium 607. J Bacteriol 1970, 101:654-656.
41. dos Santos Mota JM, den Kamp JA, Verheij HM, van Deenen LL. Phospholipids of Streptococcus faecalis. J Bacteriol 1970, 104:611-619.
42. Haest CW, de Gier J, den Kamp JO, Bartels P, van Deenen LL. Chages in permeability of Staphylococcus aureus and derived liposomes with varying lipid composition. Biochim Biophys Acta 1972, 255:720-733.
43. Jones T, Yeaman MR, Sakoulas G, Yang SJ, Proctor RA, Sahl HG, Schrenzel J, Xiong YQ, Bayer AS. Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob Agents Chemother 2008, 52:269-278.
44. Komatsuzawa H, Ohta K, Fujiwara T, Choi GH, Labischinski H, Sugai M. Cloning and sequencing of the gene, fmtC, which affects oxacillin resistance in methicillin-resistant Staphylococcus aureus. FEMS Microbiol Lett 2001, 203:49-54.
45. Vinuesa P, Neumann-Silkow F, Pacios-Bras C, Spaink HP, Martínez-Romero E, Werner D. Genetic analysis of a pH-regulated operon from Rhizobium tropici CIAT899 involved in acid tolerance and nodulation competitiveness. Mol Plant Microbe Interact 2003, 16:159-168. Available at:
46. Andra J, Goldmann T, Ernst CM, Peschel A, Gutsmann T. Multiple peptide resistance factor (MprF)-mediated resistance of Staphylococcus aureus against antimicrobial peptides coincides with a modulated peptide interaction with artificial membranes comprising lysyl-phosphatidylglycerol. J Biol Chem 2011, 286:18692-18700.
47. van den Brink-van der Laan E, Boots JW, Spelbrink RE, Kool GM, Breukink E, Killian JA, de Kruijff B. Membrane interaction of the glycosyltransferase MurG: a special role for cardiolipin. J Bacteriol 2003, 185:3773-3779.
48. Ichihashi N, Kurokawa K, Matsuo M, Kaito C, Sekimizu K. Inhibitory effects of basic or neutral phospholipid on acidic phospholipid-mediated dissociation of adenine nucleotide bound to DnaA protein, the initiator of chromosomal DNA replication. J Biol Chem 2003, 278:28778-28786. Available at:
49. Ruzin A, Severin A, Moghazeh SL, Etienne J, Bradford PA, Projan SJ, Shlaes DM. Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus. Biochim Biophys Acta 2003, 1621:117-121. Available at:
50. Nishi H, Komatsuzawa H, Fujiwara T, McCallum N, Sugai M. Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus. Antimicrob Agents Chemother 2004, 48:4800-4807.
51. Pillai SK, Gold HS, Sakoulas G, Wennersten C, Moellering RC, Eliopoulos GM. Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF. Antimicrob Agents Chemother 2007, 51:2223-2225. Available at:
52. Rose WE, Rybak MJ, Tsuji BT, Kaatz GW, Sakoulas G. Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function. J Antimicrob Chemother 2007, 59:1190-1193.
53. Boucher HW, Sakoulas G. Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus. Clin Infect Dis 2007, 45:601-608. Available at:
54. Camargo ILBdC, Neoh H-M, Cui L, Hiramatsu K. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype. Antimicro Agents Chemother 2008, 52:4289-4299. Available at:
55. Rose WE, Leonard SN, Sakoulas G, Kaatz GW, Zervos MJ, Sheth A, Carpenter CF, Rybak MJ. Daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 2008, 52:831-836.
56. Li M, Lai Y, Vil laruz A, Cha D, Sturdevant D, Otto M. Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci 2007, 104:9469. Available at:
57. Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol 2007, 66:1136-1147. Available at:
58. Otto M. Bacterial sensing of antimicrobial peptides. Contrib Microbiol 2009, 16:136-149.
59. Matsuo M, Oogai Y, Kato F, Sugai M, Komatsuzawa H. Growth-phase dependence of susceptibility to antimicrobial peptides in Staphylococcus aureus. Microbiology 2011, 157:1786-1797.
60. Mandin P, Fsihi H, Dussurget O, Vergassola M, Milohanic E, Toledo-Arana A, Lasa I, Johansson J, Cossart P. VirR, a response regulator critical for Listeria monocytogenes virulence. Mol Microbiol 2005, 57:1367-1380. Available at:
61. Vollmer W, Blanot D, de Pedro MA. Peptidoglycan structure and architecture. FEMS Microbiol Rev 2008, 32:149-167.
62. Dramsi S, Magnet S, Davison S, Arthur M. Covalent attachment of proteins to peptidoglycan. FEMS Microbiol Rev 2008, 32:307-320.
63. Ton-That H, Labischinski H, Berger-Bachi B, Schneewind O. Anchor structure of staphylococcal surface proteins. III. Role of the FemA, FemB, and FemX factors in anchoring surface proteins to the bacterial cell wall. J Biol Chem 1998, 273:29143-29149.
64. Walsh CT, Fisher SL, Park IS, Prahalad M, Wu Z. Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story. Chem Biol 1996, 3:21-28.
65. Stranden AM, Ehlert K, Labischinski H, Berger-Bachi B. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. J Bacteriol 1997, 179:9-16.
66. Filipe SR, Severina E, Tomasz A. The role of murMN operon in penicillin resistance and antibiotic tolerance of Streptococcus pneumoniae. Microb Drug Resist 2002, 7:303-316. Available at:
67. Weber B, Ehlert K, Diehl A, Reichmann P, Labischinski H, Hakenbeck R. The fib locus in Streptococcus pneumoniae is required for peptidoglycan crosslinking and PBP-mediated β-lactam resistance. FEMS Microbiol Lett 2000, 188:81-85.
68. Bouhss A, Josseaume N, Severin A, Tabei K, Hugonnet J-E, Shlaes D, Mengin-Lecreulx D, Van Heijenoort J, Arthur M. Synthesis of the L-alanyl-L-alanine cross-bridge of Enterococcus faecalis peptidoglycan. J Biol Chem 2002, 277:45935-45941. Available at:
69. Arbeloa A, Hugonnet JE, Sentilhes AC, Josseaume N, Dubost L, Monsempes C, Blanot D, Brouard JP, Arthur M. Synthesis of mosaic peptidoglycan cross-bridges by hybrid peptidoglycan assembly pathways in gram-positive bacteria. J Biol Chem 2004, 279:41546-41556.
70. Mainardi JL, Villet R, Bugg TD, Mayer C, Arthur M. Evolution of peptidoglycan biosynthesis under the selective pressure of antibiotics in Gram-positive bacteria. FEMS Microbiol Rev 2008, 32:386-408.
71. Zapun A, Contreras-Martel C, Vernet T. Penicillin-binding proteins and β-lactam resistance. FEMS Microbiol Rev 2008, 32:361-385.
72. Bellais S, Arthur M, Dubost L, Hugonnet JE, Gutmann L, van Heijenoort J, Legrand R, Brouard JP, Rice L, Mainardi JL. Aslfm, the D-aspartate ligase responsible for the addition of D-aspartic acid onto the peptidoglycan precursor of Enterococcus faecium. J Biol Chem 2006, 281:11586-11594.
73. Tschierske M, Mori C, Rohrer S, Ehlert K, Shaw KJ, Berger-Bachi B. Identification of three additional femAB-like open reading frames in Staphylococcus aureus. FEMS Microbiol Lett 1999, 171:97-102.
74. Berger-Bachi B, Barberis-Maino L, Strassle A, Kayser FH. FemA, a host-mediated factor essential for methicillin resistance in Staphylococcus aureus: molecular cloning and characterization. Mol Gen Genet 1989, 219:263-269.
75. Berger-Bachi B, Strassle A, Gustafson JE, Kayser FH. Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1992, 36:1367-1373.
76. de Lencastre H, Tomasz A. Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1994, 38:2590-2598.
77. Lavollay M, Arthur M, Fourgeaud M, Dubost L, Marie A, Veziris N, Blanot D, Gutmann L, Mainardi JL. The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by L, D-transpeptidation. J Bacteriol 2008, 190:4360-4366.
78. Mahapatra S, Crick DC, McNeil MR, Brennan PJ. Unique structural features of the peptidoglycan of Mycobacterium leprae. J Bacteriol 2008, 190:655-661.
79. Hong HJ, Hutchings MI, Hill LM, Buttner MJ. The role of the novel Fem protein VanK in vancomycin resistance in Streptomyces coelicolor. J Biol Chem 2005, 280:13055-13061.
80. Yanagihara Y, Kamisango K, Yasuda S, Kobayashi S, Mifuchi I, Azuma I, Yamamura Y, Johnson RC. Chemical compositions of cell walls and polysaccharide fractions of spirochetes. Microbiol Immunol 1984, 28:535-544.
81. Rohrer S, Ehlert K, Tschierske M, Labischinski H, Berger-Bachi B. The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation. Proc Natl Acad Sci U S A 1999, 96:9351-9356.
82. Umemoto T, Ota T, Sagawa H, Kato K, Takada M, Tsujimoto M, Kawasaki A, Ogawa T, Harada K, Kotani S. Chemical and biological properties of a peptidoglycan isolated from Treponema pallidum kazan. Infect Immun 1987, 31:767-774.
83. Pootoolal J, Thomas MG, Marshall CG, Neu JM, Hubbard BK, Walsh CT, Wright GD. Assembling the glycopeptide antibiotic scaffold: the biosynthesis of A47934 from Streptomyces toyocaensis NRRL15009. PNAS 2002, 99:8962-8967.
84. Schleifer KH, Kandler O. Amino acid sequence of the mureinof Planococcus and other Micrococcaceae. J Bacteriol 1970, 103:387-392.
85. Ghuysen JM, Tipper DJ, Birge CH, Strominger JL. Structure of the cell wall of Staphylococcus aureus, strain Copenhagen. VI. The soluble glycopeptide and its sequential degredation by peptidases. Biochemistry 1965, 4:2244-2254.
86. Tipper DJ. Structures of the cell wall peptidoglycans of Staphylococcus epidermidis Texas 26, and Staphylococcus aureus Copenhagen. II. Structure of the neutral and basic peptides from hydrolysis with the Myxobacter al-1 peptidase. Biochemistry 1969, 8:2192-2202.
87. Filipe SR, Severina E, Tomasz A. Functional analysis of Streptococcus pneumoniae MurM reveals the region responsible for its specificity in the synthesis of branched cell wall peptides. J Biol Chem 2001, 276:39618-39628.
88. van Heijenoort J, Gutmann L. Correlation between the structure of the bacterial peptidoglycan monomer unit, the specificity of transpeptidation, and susceptibility to β-lactams. Proc Natl Acad Sci U S A 2000, 97:5028-5030.
89. Tschierske M, Mori C, Rohrer K, Ehlert K, Shaw KJ, Berger-Bächi B. Identification of three additional femAB-like open reading frames in Staphylococcus aureus. FEMS Microbiol Lett 1999, 171:97-102.
90. Krulwich TA, Ensign JC, Tipper DJ, Strominger JL. Sphere-rod morphogenesis in Arthrobacter crystallopoietes. I. Cell wall composition and polysaccharides of the peptidoglycan. J Bacteriol 1967, 94:741-750.
91. Holzapfel W, Kandler O. Taxonomy of the species Lactobacillus Beijerinck. VI. Lactobacillis coprophilus subsp. confusus nov. subsp., a new variety of the subspecies Betabacterium. Zentrabl Bakteriol Parasitenk Infektionskr Hyg Abt 2 1969, 123:657-666.
92. Beatson S, Sloan G, Simmonds R. Zoocin A immunity factor: a femA-like gene found in a group C streptococcus. FEMS Microbiol Lett 1998, 163:73-77.
93. Weber B, Ehlert K, Diehl A, Reichmann P, Labischinski H, Hakenbeck R. The fib locus in Streptococcus pneumoniae is required for peptidoglycan crosslinking and PBP-mediated β-lactam resistance. FEMS Microbiol Lett 2000, 188:81-85.
94. Petit JF, Munoz E, Ghuysen JM. Peptide cross-links in bacterial cell wall peptidoglycans studied with specific endopeptidases from Streptomyces albus G. Biochemistry 1966, 5:2764-2776.
95. Schleifer KH, Kandler O. On the chemical composition of the cell wall of streptococci. I. The amino acid sequence of the murein of Str. thermophilus and Str. faecalis. Arch Mikrobiol 1967, 57:335-364.
96. Fiedler F, Schleifer KH, Cziharz B, Interschick E, Kandler O. Murein types in Arthrobacter, Brevibacteria, Corynebacteria, and Microbacteria. Publ Fac Sci Univ J E Purkyne Brno 1970, 47:111-122.
97. Schleifer KH, Kandler O. On the chemical composition of the cell wall of Streptococci. 3. The amino acid sequence of a glycine-containing murein from Peptostreptococcus evolutus (Prevot) Smith. Arch Mikrobiol 1968, 61:292-301.
98. Schleifer KH. Substrate modifications of the amino acid sequence of the murein of staphylococci. J Gen Microbiol 1969, 57:XIV.
99. Alborn WE, Hoskins JJ, Unal S, Flokowitsch JE, Hayes CA, Dutzlaf JE, Yeh WK, Skatrud PL. Cloning and characterization of femA and femB from Staphylococcus epidermidis. Gene 1996, 180:177-181.
100. DeHart HP, Heath LS, LeBlanc PA, Sloan GL. The lysosyaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus. App Environ Microbiol 1995, 61:1475-1479.
101. Thumm G, Götz F. Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus. Mol Microbiol 1997, 23:1251-1256.
102. Ehlert K, Tschierske M, Mori C, Schroder W. Site-specific serine incorporation by Lif and Epr into positions 3 and 5 of the staphylococcal peptidoglycan interpeptide bridge. J Bact 2000, 182:2635-2638.
103. Schleifer KH, Huss L, Kandler O. The effect of nutrition on the amino acid sequence of the serine containing murein of Staphylococcus epidermis Strain 24. Arch Mikrobiol 1969, 68:387-404.
104. Kandler O, Plapp R, Holzapfel W. The amino acid sequence of the serine-containing mureins of Lactobacillus viridescens and Leuconostoc. Biochim Biophys Acta 1967, 147:252-261.
105. Schneider T, Senn MM, Berger-Bächi B, Tossi A, Sahl H-G, Wiedemann I. In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus. Mol Microbiol 2004, 53:675-685. Available at:
106. Severin A, Vaz Pato MV, Sá Figueiredo AM, Tomasz A. Drastic changes in the peptidoglycan composition of penicillin resistant laboratory mutants of Streptococcus pneumoniae. FEMS Microbiol Lett 1995, 130:31-35.
107. Kandler O. Amino acid sequence of the murein and taxonomy of the genera Lactobacillus, Bifidobacterium, Leuconostoc and Pediococcus. Int J Syst Bacteriology 1970, 20:491-507.
108. Hladny J, Schleifer KH, Kandler O. The amino acid sequence of the threonine containing mureins of some species of Streptococcus. Arch Mikrobiol 1972, 85:23-38.
109. Beukes M, Hastings JW. Self-protection against cell wall hydrolysis in Streptococcus milleri NMSCC 061 and analysis of the millercin B operon. Appl Environ Microbiol 2001, 67:3888-3896.
110. Ghuysen JM. Use of bacteriolytic enzymes in determination of wall structure and their role in cell metabolism. Bacteriol Rev 1968, 32:425-464.
111. Holzapfel, Scardovi V, Kandler O. Amino acid sequence of the ornithine and lysine containing murein of some strains of Lactobacillus bifidus from rumen. Z Naturforsch 1969, 24b:1524-1528.
112. Koch D, Schleifer KH, Kandler O. The amino acid sequence of the serine and aspartic acid containing mureins of Bifidobacterium bifidum Oria Jensen. Z Naturforsch B 1970, 25:1294-1301.
113. Schleifer KH, Plapp R, Kandler O. Glycine as crosslinking bridge in the L, L-diaminopinelic acid containing murein of Propionibacterium petersonii. Fed Eur Biochem Soc Lett 1968, 1:287-289.
114. Arima K, Nakamura T, Tamura G. Chemical structure of the mucopeptide of Streptomyces roseochromogenes cell wall. Agr Biol Chem 1968, 32:530-531.
115. De Pascale G, Lloyd AJ, Schouten JA, Gilbey AM, Roper DI, Dowson CG, Bugg TD. Kinetic characterization of lipid II-Ala:alanyl-tRNA ligase (MurN) from Streptococcus pneumoniae using semisynthetic aminoacyl-lipid II substrates. J Biol Chem 2008, 283:34571-34579.
116. Filipe SR, Tomasz A. Inhibition of the expression of penicillin resistance in Streptococcus pneumoniae by inactivation of cell wall muropeptide branching genes. Proc Natl Acad Sci U S A 2000, 97:4891-4896.
117. Lloyd AJ, Gilbey AM, Blewett AM, De Pascale G, El Zoeiby A, Levesque RC, Catherwood AC, Tomasz A, Bugg TDH, Roper DI, et al. Characterization of tRNA-dependent peptide bond formation by MurM in the synthesis of Streptococcus pneumoniae peptidoglycan. J Biol Chem 2008, 283:6402-6417. Available at:
118. Ehlert K, Schroder W, Labischinski H. Specificities of FemA and FemB for different glycine residues: FemB cannot substitute for FemA in staphylococcal peptidoglycan pentaglycine side chain formation. J Bacteriol 1997, 179:7573-7576.
119. Green CJ, Vold BS. Staphylococcus aureus has clustered tRNA genes. J Bacteriol 1993, 175:5091-5096.
120. Bouhss A, Josseaume N, Allanic D, Crouvoisier M, Gutmann L, Mainardi JL, Mengin-Lecreulx D, van Heijenoort J, Arthur M. Identification of the UDP-MurNAc-pentapeptide:L-alanine ligase for synthesis of branched peptidoglycan precursors in Enterococcus faecalis. J Bacteriol 2001, 183:5122-5127. Available at:
121. Hegde S, Shrader T. FemABX family members are novel nonribosomal peptidyltransferases and important pathogen-specific drug targets. J Biol Chem 2001, 276:6998-7003. Available at:
122. Benson TE, Prince DB, Mutchler VT, Curry KA, Ho AM, Sarver RW, Hagadorn JC, Choi GH, Garlick RL. X-ray crystal structure of Staphylococcus aureus FemA. Structure 2002, 10:1107-1115. Available at:
123. Biarrotte-Sorin S, Maillard AP, Delettré J, Sougakoff W, Arthur M, Mayer C. Crystal structures of Weissella viridescens FemX and its complex with UDP-MurNAc-pentapeptide: insights into FemABX family substrates recognition. Structure 2004, 12:257-267. Available at:
124. Dutnall RN, Tafrov ST, Sternglanz R, Ramakrishnan V. Structure of the histone acetyltransferase Hat1: a paradigm for the GCN5-related N-acetyltransferase superfamily. Cell 1998, 94:427-438.
125. Fiser A, Filipe SR, Tomasz A. Cell wall branches, penicillin resistance and the secrets of the MurM protein. Trends Microbiol 2003, 11:547-553.
126. Biou V, Yaremchuk A, Tukalo M, Cusack S. The 2.9 A crystal structure of T. thermophilus seryl-tRNA synthetase complexed with tRNA(Ser). Science 1994, 263:1404-1410.
127. Cusack S, Yaremchuk A, Tukalo M. The crystal structure of the ternary complex of T.thermophilus seryl-tRNA synthetase with tRNA(Ser) and a seryl-adenylate analogue reveals a conformational switch in the active site. EMBO J 1996, 15:2834-2842.
128. Maillard AP, Biarrotte-Sorin S, Villet R, Mesnage S, Bouhss A, Sougakoff W, Mayer C, Arthur M. Structure-based site-directed mutagenesis of the UDP-MurNAc-pentapeptide-binding cavity of the FemX alanyl transferase from Weissella viridescens. J Bacteriol 2005, 187:3833-3838. Available at:
129. Hegde SS, Blanchard JS. Kinetic and mechanistic characterization of recombinant Lactobacillus viridescens FemX (UDP-N-acetylmuramoyl pentapeptide-lysine N6-alanyltransferase). J Biol Chem 2003, 278:22861-22867.
130. Giannouli S, Kyritsis A, Malissovas N, Becker HD, Stathopoulos C. On the role of an unusual tRNAGly isoacceptor in Staphylococcus aureus. Biochimie 2009, 91:344-351. Available at:
131. Villet R, Fonvielle M, Busca P, Chemama M, Maillard AP, Hugonnet J-E, Dubost L, Marie A, Josseaume N, Mesnage S, et al. Idiosyncratic features in tRNAs participating in bacterial cell wall synthesis. Nucleic Acids Res 2007, 35:6870-6883. Available at:
132. Fonvielle M, Chemama M, Villet R, Lecerf M, Bouhss A, Valery JM, Etheve-Quelquejeu M, Arthur M. Aminoacyl-tRNA recognition by the FemXWv transferase for bacterial cell wall synthesis. Nucleic Acids Res 2009, 37:1589-1601.
133. Cressina E, Lloyd AJ, De Pascale G, Roper DI, Dowson CG, Bugg TD. Adenosine phosphonate inhibitors of lipid II: alanyl tRNA ligase MurM from Streptococcus pneumoniae. Bioorg Med Chem Lett 2007, 17:4654-4656.
134. Cressina E, Lloyd AJ, De Pascale G, James Mok B, Caddick S, Roper DI, Dowson CG, Bugg TD. Inhibition of tRNA-dependent ligase MurM from Streptococcus pneumoniae by phosphonate and sulfonamide inhibitors. Bioorg Med Chem 2009, 17:3443-3455.
135. Chemama M, Fonvielle M, Arthur M, Valery JM, Etheve-Quelquejeu M. Synthesis of stable aminoacyl-tRNA analogues containing triazole as a bioisoster of esters. Chemistry 2009, 15:1929-1938.
136. Chemama M, Fonvielle M, Villet R, Arthur M, Valery JM, Etheve-Quelquejeu M. Stable analogues of aminoacyl-tRNA for inhibition of an essential step of bacterial cell-wall synthesis. J Am Chem Soc 2007, 129:12642-12643.